The MedGuard Pro Series incorporates silver-ion infused finishes that kill 99.9% of bacteria (including E. coli and Staphylococcus aureus) within 24 hours, preventing the spread of germs in high-traffic healthcare environments. The flooring also meets ISO 10993 biocompatibility standards, ensuring it’s safe for patients with sensitive skin or compromised immune systems.
Beyond hygiene, the flooring delivers clinical-grade performance: 60% shock absorption for rehabilitation exercises, a non-slip surface (friction coefficient ≥0.8) for patients using mobility aids, and durability to withstand wheelchairs and medical equipment. Early adopters include the Mayo Clinic’s Sports Medicine Center and London’s Royal Brompton Hospital, which have installed the flooring in their therapy gyms.
“Hygiene and performance are equally critical in healthcare sports facilities,” said Dr. James Harper, Limei’s Medical Sector Advisor. “MedGuard Pro addresses both needs, providing a safe, durable surface that supports patient recovery while minimizing infection risk.” The series launched globally in Q3 2027, with applications in physical therapy and hospital wellness zones.
